Identification of Responders to Immune Checkpoint Therapy: Which Biomarkers Have the Highest Value?

Journal of the European Academy of Dermatology and Venereology - United States
doi 10.1111/jdv.15992
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Wiley

Related search

Immune Checkpoint Therapy and the Search for Predictive Biomarkers

Cancer Journal
Cancer ResearchOncology
2016English

Sensitizing the Tumor Microenvironment to Immune Checkpoint Therapy

Frontiers in Immunology
AllergyImmunology
2020English

The Genomic Landscape of Merkel Cell Carcinoma and Clinicogenomic Biomarkers of Response to Immune Checkpoint Inhibitor Therapy

Clinical Cancer Research
Cancer ResearchOncology
2019English

Hypokalemic Paralysis Secondary to Immune Checkpoint Inhibitor Therapy

Case Reports in Oncological Medicine
Oncology
2017English

Biomarkers for Immune Checkpoint Inhibitors: The Importance of Tumor Topography and the Challenges to Cytopathology

Cancer cytopathology
Cancer ResearchOncology
2017English

On the Mechanism of Anti-Cd39 Immune Checkpoint Therapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2020English

Neutrophil Lymphocyte Ratio and Duration of Prior Anti-Angiogenic Therapy as Biomarkers in Metastatic RCC Receiving Immune Checkpoint Inhibitor Therapy

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2017English

Current Landscape and Future Directions of Biomarkers for Predicting Responses to Immune Checkpoint Inhibitors

Cancer Management and Research
Oncology
2018English

Systemic Immunological Biomarkers of Clinical Responses in Immune Checkpoint Blockade Therapies

Lung Cancer Management
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy